Company Profile
Pacific Shuanglin Bio-pharmacy researches, develops, produces, and sells blood products in China and globally. The company offers human serum albumin, human immunoglobulin (PH4), human immunoglobulin, hepatitis B human immunoglobulin, tetanus immunoglobulin, rabies immunoglobulin, human coagulation factor VIII, human fibrinogen, lyophilized intravenous immunoglobulin (pH4), hepatitis B immunoglobulin (pH4), and human prothrombin complex concentrate
Intravenous cytomegalovirus immunoglobulin and intravenous respiratory syncytial virus immunoglobulin. It is also involved in blood acquisition. Its portfolio also includes plasma collection, consulting, trading, investment activities, and technology promotion and application services.
Founded in 1993 and headquartered in Taiyuan, China, Pacific Shuanglin Bio-pharmacy was formerly known as Southern Shuanglin Bio-pharmacy Co., Ltd. before rebranding in April 2021.